Cyklokapron 500 Mg Film-Coated Tablets
Out of date information, search anotherMeda Pharmaceuticals Ltd
Cyklokapron 500 mg Film-coated Tablets
1-2-form-present-and-proposed-table
National Type IA-C.I.z Variation
to implement statuatory wording concerning reporting suspected adverse reactions Cyklokapron 500 mg Film-coated Tablets PL 15142/0130
Module 1.2 PRESENT AND PROPOSED TABLE
PRESENT SPC |
PROPOSED SPC |
4.8 UNDESIRABLE EFFECTS |
4.8 UNDESIRABLE EFFECTS |
Adverse events are listed below by system organ class and frequency. Frequencies are defined as: very common (>1/l0), common (>1/100 and <1/10), uncommon (>1/1000 and <1/100), rare (> 1/10,000 and <1/1000) and very rare (<1/10,000) including isolated reports, not known (cannot be estimated from the available data). |
Adverse events are listed below by system organ class and frequency. Frequencies are defined as: very common (>1/l0), common (>1/100 and <1/10), uncommon (>1/1000 and <1/100), rare (> 1/10,000 and <1/1000) and very rare (<1/10,000) including isolated reports, not known (cannot be estimated from the available data). |
Immune system disorders Very rare: Hypersensitivity reactions including anaphylaxis |
Immune system disorders Very rare: Hypersensitivity reactions including anaphylaxis |
Eye disorders Rare: Colour vision disturbances, retinal/artery occlusion |
Eye disorders Rare: Colour vision disturbances, retinal/artery occlusion |
Vascular disorders Rare: Thromboembolic events Very rare: Arterial or venous thrombosis at any sites |
Vascular disorders Rare: Thromboembolic events Very rare: Arterial or venous thrombosis at any sites |
Gastro-intestinal disorders Very rare: Digestive effects such as nausea, vomiting and diarrhoea, may occur but disappear when the dosage is reduced. |
Gastro-intestinal disorders Very rare: Digestive effects such as nausea, vomiting and diarrhoea, may occur but disappear when the dosage is reduced. |
Skin and subcutaneous tissue disorders |
Skin and subcutaneous tissue disorders |
Rare: Allergic skin reactions |
Rare: Allergic skin reactions Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. |
10. DATE OF REVISION OF THE TEXT |
10. DATE OF REVISION OF THE TEXT |
4th July 2013 |
26th November 2013 |
PRESENT PIL |
PROPOSED PIL |
4. Possible side effects |
4. Possible side effects |
Like all medicines Cyklokapron can cause side effects, although not everybody gets them. |
Like all medicines Cyklokapron can cause side effects, although not everybody gets them. |
Eye disorders Rare (affects 1 to 10 users in 1,000) - Problems with your eyesight, especially your colour vision. - A blood clot in your eye. This may cause bleeding in the eye, or a loss of vision |
Eye disorders Rare (affects 1 to 10 users in 1,000) - Problems with your eyesight, especially your colour vision. - A blood clot in your eye. This may cause bleeding in the eye, or a loss of vision |
Immune system disorders Very rare (affects less than 1 user in 10,000) - this includes allergic reactions which cause difficulty in breathing or dizziness. |
Immune system disorders Very rare (affects less than 1 user in 10,000) - this includes allergic reactions which cause difficulty in breathing or dizziness. |
Vascular disorders |
Vascular disorders |
Very rare (affects less than 1 user in 10,000) - A blood clot in your blood vessels (called a 'thrombosis’). |
Very rare (affects less than 1 user in 10,000) - A blood clot in your blood vessels (called a 'thrombosis’). |
Gastrointestinal disorders Very rare (affects less than 1 user in 10,000) - Feeling sick - Being sick - Diarrhoea |
Gastrointestinal disorders Very rare (affects less than 1 user in 10,000) - Feeling sick - Being sick - Diarrhoea |
These are usually mild and pass very quickly, but if they continue, tell your doctor or pharmacist. |
These are usually mild and pass very quickly, but if they continue, tell your doctor or pharmacist. |
Skin and subcutaneous tissue disorders Rare (affects 1 to 10 users in 1,000) - Itchy, red or swollen skin |
Skin and subcutaneous tissue disorders Rare (affects 1 to 10 users in 1,000) - Itchy, red or swollen skin |
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. |
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. |
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. | |
6. Further information |
6. Further information |
This leaflet was last updated in 03/2011. |
This leaflet was last updated in November 2013. |
Page 3 of 3
November 2013